NCT01861899

Brief Summary

The objective of this study is to gather clinical data on SI-LOK® for the treatment of sacroiliac joint dysfunction. The purpose of this prospective study is to evaluate clinical and radiographic outcomes, intra-operative parameters, patient satisfaction and work status following a procedure using SI-LOK® for treatment of sacroiliac joint dysfunction with a minimum of three screws.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2013

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 21, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 24, 2013

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2019

Completed
Last Updated

September 11, 2020

Status Verified

September 1, 2020

Enrollment Period

5.2 years

First QC Date

May 21, 2013

Last Update Submit

September 9, 2020

Conditions

Keywords

Sacro-iliac Joint

Outcome Measures

Primary Outcomes (1)

  • Radiographic Evaluation

    Fusion Assessment Radiolucency

    2 years

Secondary Outcomes (1)

  • Hospitalization Data

    Intra-Operative

Other Outcomes (1)

  • Composite of Patient Self-Assessments

    2 years

Study Arms (1)

SI-Joint Dysfunction

Device- SI-LOK

Device: SI-LOK

Interventions

SI-LOKDEVICE

Sacro-iliac joint fusion

SI-Joint Dysfunction

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be screened according to inclusion/exclusion criteria and will be selected for the treatment using the SI-LOK® system

You may qualify if:

  • A maximum age of 70 years
  • Diagnosis of SIJ dysfunction
  • Ability to provide Informed Consent for study participation and to return for all follow-up visits

You may not qualify if:

  • Previous documentation of osteopenia or osteomalacia
  • History of metabolic bone disease (e.g. diabetes requiring daily insulin)
  • Diagnosis of a condition or requires postoperative medication(s), which may interfere with bony/soft tissue healing
  • Presence of a disease entity or condition which totally precludes possibility of bony fusion (e.g. metastatic cancer, HIV, long term use of steroids, etc.)
  • History of substance abuse (drugs or alcohol)
  • Condition that would preclude completing patient self assessment questionnaires
  • Mentally incompetent or prisoner
  • Currently a participant in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Medical Center

Saint Albans, Vermont, 05478, United States

Location

MeSH Terms

Conditions

Joint Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases

Study Officials

  • Michael Barnum, MD

    Northwestern Medical Center, St Albans, VT 05478

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2013

First Posted

May 24, 2013

Study Start

May 2, 2013

Primary Completion

July 5, 2018

Study Completion

April 11, 2019

Last Updated

September 11, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations